Oesch-Bartlomowicz B, Vogel S, Arens H J, Oesch F
Institute of Toxicology, University of Mainz, F.R.G.
Mutat Res. 1990 Oct;232(2):305-12. doi: 10.1016/0027-5107(90)90137-s.
The phosphorylation of the 2 major phenobarbital-inducible cytochrome P450 isoenzymes IIB1 and IIB2 was increased in intact hepatocytes by the action of the membrane-permeating cAMP derivative N6,O2'-dibutyryl-cAMP. Under these conditions cyclophosphamide and ifosfamide (which are known to be activated by cytochrome P450 IIB1) were investigated for mutagenicity in Salmonella typhimurium TA1535 and TA100 and for cytotoxicity in TA1535. Cyclophosphamide and ifosfamide were transformed to mutagenic and cytotoxic metabolites by the hepatocytes. The activation of both drugs to mutagens was markedly reduced after pretreatment of the hepatocytes with the membrane-permeating cAMP derivative N6,O2'-dibutyryl-cAMP. Cyclophosphamide and ifosfamide activation were reduced to 51% and 38% of unstimulated controls respectively, when hepatocytes were incubated for 1 h with N6,O2'-dibutyryl-cAMP in the presence of the phosphodiesterase inhibitor theophylline, and Salmonella typhimurium TA1535 was used. A marked reduction in mutagenicity of cyclophosphamide (35% compared with unstimulated controls) was also observed under different experimental conditions, namely after pretreatment of the hepatocytes with N6,O2'-dibutyryl-cAMP for 1.5 h without theophylline and using Salmonella typhimurium TA100 as target strain. Continued presence of the cytochrome P450 IIB1 and P450 IIB2 inducer phenobarbital in the stimulation medium increased the mutagenicity of cyclophosphamide and led to an even more marked reduction of mutagenicity by pretreatment of the hepatocytes with N6,O2'-dibutyryl-cAMP and theophylline. In order to investigate whether the observed changes were metabolism-related, the ifosfamide metabolite ifosfamide mustard which does not require metabolic activation by cytochrome P450 was studied under the same conditions. Its mutagenicity was indistinguishable after incubation with N6,O2'-dibutyryl-cAMP-treated or with unstimulated hepatocytes. Also the metabolic formation of cytotoxic metabolites from cyclophosphamide and ifosfamide but not that of ifosfamide mustard was markedly decreased by pretreatment of the hepatocytes with N6,O2'-dibutyryl-cAMP and theophylline. Thus the stimulation of protein kinase A in intact cells has important consequences for the control of genotoxic and cytotoxic metabolites and represents a fast and short-term regulation of it.
在完整的肝细胞中,膜通透性环磷酸腺苷(cAMP)衍生物N6,O2'-二丁酰-cAMP的作用可使两种主要的苯巴比妥诱导型细胞色素P450同工酶IIB1和IIB2的磷酸化增加。在此条件下,研究了环磷酰胺和异环磷酰胺(已知可被细胞色素P450 IIB1激活)在鼠伤寒沙门氏菌TA1535和TA100中的致突变性以及在TA1535中的细胞毒性。环磷酰胺和异环磷酰胺被肝细胞转化为具有致突变性和细胞毒性的代谢产物。在用膜通透性cAMP衍生物N6,O2'-二丁酰-cAMP预处理肝细胞后,两种药物向诱变剂的转化均显著降低。当肝细胞在磷酸二酯酶抑制剂茶碱存在下与N6,O2'-二丁酰-cAMP孵育1小时,并使用鼠伤寒沙门氏菌TA1535时,环磷酰胺和异环磷酰胺的激活分别降至未刺激对照的51%和38%。在不同的实验条件下,即在没有茶碱的情况下,用N6,O2'-二丁酰-cAMP预处理肝细胞1.5小时,并使用鼠伤寒沙门氏菌TA100作为靶菌株,也观察到环磷酰胺的致突变性显著降低(与未刺激对照相比为35%)。刺激培养基中持续存在细胞色素P450 IIB1和P450 IIB2诱导剂苯巴比妥会增加环磷酰胺的致突变性,并导致在用N6,O2'-二丁酰-cAMP和茶碱预处理肝细胞后致突变性的降低更为显著。为了研究观察到的变化是否与代谢有关,在相同条件下研究了不需要细胞色素P450代谢激活的异环磷酰胺代谢产物异环磷酰胺氮芥。与用N6,O2'-二丁酰-cAMP处理的肝细胞或未刺激的肝细胞孵育后,其致突变性没有差异。用N6,O2'-二丁酰-cAMP和茶碱预处理肝细胞也显著降低了环磷酰胺和异环磷酰胺细胞毒性代谢产物的代谢形成,但异环磷酰胺氮芥的代谢形成没有降低。因此,完整细胞中蛋白激酶A的刺激对遗传毒性和细胞毒性代谢产物的控制具有重要影响,代表了对其快速和短期的调节。